Cefadroxil Pregnancy and Breastfeeding Warnings
Cefadroxil is also known as: Duricef
Cefadroxil Pregnancy Warnings
The Michigan Medicaid surveillance study does not reveal an association between cefadroxil and congenital defects. This report is a summary of information from two studies, one in which 99 of 104,000 pregnant women from 1980 to 1983, and one in which 722 of 229,000 pregnant women from 1985 to 1992 received cefadroxil. In the first study, eight total defects and one cardiovascular defect were observed (six and one were expected, respectively). In the second study, fewer total and cardiovascular defects were observed than expected. Cleft palate was not observed in either study.
Cefadroxil has been assigned to pregnancy category B by the FDA. Animal studies failed to reveal evidence of fetal harm. There are no controlled data in human pregnancy. Cefadroxil should only be given during pregnancy when need has been clearly established.
Cefadroxil Breastfeeding Warnings
Following a single 1 gram oral dose to six lactating women, peak milk cefadroxil levels were observed at six to seven hours, averaging 1.83 mcg per mL. These levels are low and are not expected to cause adverse effects in nursing infants.
Cefadroxil is excreted into human milk in small amounts. However, no adverse effects in nursing infants have been reported. Cefadroxil is considered compatible with breast-feeding by the American Academy of Pediatrics.
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.